Bulletin from the extraordinary general meeting in Klaria Pharma Holding AB (publ)
At the extraordinary general meeting held in Klaria Pharma Holding AB (publ) today on 30 December 2021, it was resolved (all in accordance with the proposals presented in the notice to attend the meeting kept available at the company’s website www.klaria.com):· It was resolved to approve an addendum agreement with FFT Medical AB in order to finally settle the purchase price for Klaria’s acquisition of all shares in Uppsalagruppen Medical AB from FFT Medical AB during 2019. In light of Fredrik Hübinette, chairman of the board of Klaria, owning over 20 per cent of the shares in FFT Medical AB,